A carregar...
Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates
OBJECTIVES: Drug-resistant TB remains a public health challenge. Rifamycins are among the most potent anti-TB drugs. They are known to target the RpoB subunit of RNA polymerase; however, our understanding of how rifamycin resistance is genetically encoded remains incomplete. Here we investigated rpo...
Na minha lista:
| Publicado no: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524487/ https://ncbi.nlm.nih.gov/pubmed/30793747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz048 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|